A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study.

A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study. Abstract Text:

Joanna Burger,Joanna Burger,

World War II and the Cold War have left the Unites States, and other Nations, with massive cleanup and remediation tasks for radioactive and other legacy hazardous wastes. While some sites can be cleaned up to acceptable residential risk levels, others will continue to hold hazardous wastes, which must be contained and monitored to protect human health and the environment. While media (soil, sediment, groundwater) monitoring is the usual norm at many radiological waste sites, for some situations (both biological and societal), biomonitoring may provide the necessary information to assure greater peace of mind for local and regional residents, and to protect ecologically valuable buffer lands or waters. In most cases, indicators are selected using scientific expertise and a literature review, but not all selected indicators will seem relevant to stakeholders. In this paper, I provide a model for the inclusion of stakeholders in the development of bioindicators for assessing radionuclide levels of biota in the marine environment around Amchitka Island, in the Aleutian Chain of Alaska. Amchitka was the site of three underground nuclear tests from 1965 to 1971. The process was stakeholder-initiated, stakeholder-driven, and included stakeholders during each phase. Phases included conceptualization, initial selection of biota and radionuclides, refinement of biota and radionuclide target lists, collection of biota, selection of biota and radionuclides for analysis, and selection of biota, tissues, and radionuclides for bioindicators. The process produced site-specific information on biota availability and on radionuclide levels that led to selection of site-appropriate bioindicators. I suggest that the lengthy, iterative, stakeholder-driven process described in this paper results in selection of bioindicators that are accepted by biologists, public health personnel, public-policy makers, resource agencies, regulatory agencies, subsistence hunters/fishers, and a wide range of other stakeholders. The process is applicable to other sites with ecologically important buffer lands or waters, or where contamination issues are contentious.

A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study. Publishing Authors By Initials

J Burger,J Burger,

For similar complex mixtures: radioactive pollutants: water pollutants, radioactive research abstracts see: complex mixtures: radioactive pollutants: water pollutants, radioactive research

PUBMED ID PMID:

MEDLINE DATE:

A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Environmental research

VOLUME: 105

Page Numbers: 316-23

Journal Abbreviation: Environ. Res.

ISSN: 0013-9351

DAY: 14

MONTH: 08

YEAR: 2007

A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 147621

A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study. Keywords Mesh Terms:

KEYWORDS: Water Pollutants, Radioactive

MESH TERMS: analysis

Chemical & Substance for Abstract: A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study. Information

Substance Name: Water Pollutants, Radioactive

Registry Number: 0

Grant and Affiliation Information for A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study.

AFFILIATION: Division of Life Sciences, Environmental and Occupational Health Sciences Institute, and Consortium for Risk Evaluation with Stakeholder Participation, Rutgers University, Piscataway, NJ, USA. burger@biology.rutgers.edu

Country: United States

AGENCY: United States NIEHS

GRANT: P30ES005022

ACRONYM: ES

MEDLINETA: Environ Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study Related Publications

• A framework and methods for incorporating gender-related issues in wildlife risk assessment: gender-related differences in metal levels and other contaminants as a case study.
• A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study.
• Assessment and management of risk to wildlife from cadmium.
• Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.
• Cancer stem cells and individualized therapy.
• Continuous-wave broadly tunable Cr(2+):ZnSe laser.
• Editorial comment on: Long-term tolerability of tolterodine extended release in children 5-11 years of age: results from a 12-month, open-label study.
• Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway.
• Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects.
• Mixed effects modeling of weight change associated with placebo and pregabalin administration.
• Molecular analysis of xenograft models of human cancer cachexia--possibilities for therapeutic intervention.
• Monoclonal antibodies to guinea pig interferon-gamma: Tools for cytokine detection and neutralization.
• Not Available
• Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
• Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.
• Product update.
• Protective sustainability of ecosystems using Department of Energy buffer lands as a case study.
• Quantitative thin-layer chromatography of cobalamin complexes.
• Telomerase and its potential for therapeutic intervention.
• Telomerase in cancer diagnosis and therapy: a clinical perspective.
• The assessment of alexithymia in medical settings: implications for understanding and treating health problems.
• The effect on ecological systems of remediation to protect human health.
• Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice.
• Therapeutic implications of leukemic stem cell pathways.
• Treatment seeking for alcohol and drug use disorders by immigrants to the Netherlands: retrospective, population-based, cohort study.
• [Endothelioma as variety of tubular mesothelioma of the ovary.]
• [Horner's syndrome after fracture of the first rib]
• [New knowledge and experience with the urinary organs in pregnancy.]
• [Not Available.]
• [ON TRANSVERSE PRESENTATION.]